The Impact of the SARS-CoV-2 Pandemic in PID Patients Receiving Ig Replacement Therapy

J Clin Immunol. 2021 May;41(4):733-737. doi: 10.1007/s10875-020-00958-5. Epub 2021 Jan 15.

Authors

Sukru Cekic¹, Fatih Cicek¹, Sara Sebnem Kilic²

Affiliations

¹ Department of Pediatrics, Division of Immunology and Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
² Department of Pediatrics, Division of Immunology and Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey. sebnemkl@uludag.edu.tr.

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
COVID-19 / epidemiology
COVID-19 / immunology
COVID-19 / prevention & control*
COVID-19 / transmission
Case-Control Studies
Child
Child, Preschool
Female
Hand Disinfection / standards
Humans
Immunocompromised Host*
Immunoglobulins / therapeutic use*
Infant
Male
Masks / standards
Masks / statistics & numerical data
Middle Aged
Patient Compliance / statistics & numerical data
Physical Distancing
Primary Immunodeficiency Diseases / drug therapy
Primary Immunodeficiency Diseases / immunology*
Primary Immunodeficiency Diseases / psychology
Quality of Life*
SARS-CoV-2 / immunology
SARS-CoV-2 / pathogenicity
Surveys and Questionnaires / statistics & numerical data
Young Adult

Substances

Immunoglobulins